FibroMAX: towards a new universal biomarker of liver disease?

@article{Morra2007FibroMAXTA,
  title={FibroMAX: towards a new universal biomarker of liver disease?},
  author={Rachel Morra and M. J. Munteanu and Françoise Imbert-Bismut and Djamila Messous and Vlad Ratziu and Thierry Poynard},
  journal={Expert review of molecular diagnostics},
  year={2007},
  volume={7 5},
  pages={481-90}
}
Among the noninvasive alternatives to liver biopsy, several studies have demonstrated the predictive value and a better benefit-to-risk ratio than biopsy of five combinations of simple serum biochemical markers (the super combination being FibroMAX (BioPredictive, Paris, France) in patients at risk of chronic liver diseases: FibroTest (BioPredictive) for the quantitative assessment of fibrosis; SteatoTest (BioPredictive) for the quantitative assessment of steatosis; ActiTest (BioPredictive) for… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 66 references

Diagnostic value of serum protein profiling by SELDI - TOF ProteinChip compared with a biochemical marker , FibroTest , for the diagnosis of advanced fibrosis in patients with chronic hepatitis C

R Morra, V Ratziu, P Bedossa
Aliment . Pharmacol . Ther . • 2007

Impact of adefovir dipivoxil on liver fibrosis and activity assessed with FibroTest–ActiTest in patients with chronic hepatitis B infection

T Poynard, Y Ngo, P Marcellin
J. Hepatol • 2007

Prospective comparison in Fibroscan and FibroTest in inactive hepatitis B carriers

L Castera, J Foucher, PH Bernard
J . Hepatol . • 2007

Screening for liver disease using a non-invasive biomarker in patients with diabetes

S Jacqueminet, P Lebray, R Morra
Gastroenterol. Clin. Biol • 2007

Similar Papers

Loading similar papers…